GRFS (Grifols) Days Payable : 67.65 (As of Jun. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Grifols Days Payable?

Grifols's average Accounts Payable for the three months ended in Jun. 2024 was $916 Mil. Grifols's Cost of Goods Sold for the three months ended in Jun. 2024 was $1,235 Mil. Hence, Grifols's Days Payable for the three months ended in Jun. 2024 was 67.65.

The historical rank and industry rank for Grifols's Days Payable or its related term are showing as below:

GRFS' s Days Payable Range Over the Past 10 Years
Min: 64.81 Med: 74.44 Max: 96.65
Current: 96.65

During the past 13 years, Grifols's highest Days Payable was 96.65. The lowest was 64.81. And the median was 74.44.

GRFS's Days Payable is ranked better than
56.72% of 952 companies
in the Drug Manufacturers industry
Industry Median: 85.68 vs GRFS: 96.65

Grifols's Days Payable increased from Dec. 2022 (59.97) to Jun. 2024 (67.65). It may suggest that Grifols delayed paying its suppliers.

Grifols Days Payable Historical Data

The historical data trend for Grifols's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Days Payable Chart

Grifols Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

76.59

67.03

78.44

66.80

67.88

Grifols Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial															59.97	61.85	-	68.72	67.65

Competitive Comparison of Grifols's Days Payable

For the Drug Manufacturers - General subindustry, Grifols's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grifols's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grifols's Days Payable distribution charts can be found below:

* The bar in red indicates where Grifols's Days Payable falls into.

Grifols Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Grifols's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (775.337	+	886.711)	/	2 )	/	4468.273	*	365
=	831.024					/	4468.273	*	365
=	67.88

Grifols's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (886.711	+	944.804)	/	2 )	/	1235.161	*	365 / 4
=	915.7575					/	1235.161	*	365 / 4
=	67.65

Grifols Days Payable Related Terms

Thank you for viewing the detailed overview of Grifols's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Grifols Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (NAS:GRFS) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

GIKLY:USA GIFOF:USA GIFLF:USA GRFe:UK GRFPe:UK 0RDV:UK 0RDU:UK GRF.P:Spain GRF:Spain G0FB:Germany OZTA:Germany OZTA:Germany G0FB:Germany GRF:Austria

Address

Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174

Website

https://www.grifols.com

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.